These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1631508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S, Scarda A, Medori C, Valtorta C, Antonelli R, Tabolli S, Rossi W, Mazzuoli G.
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T, Boryń M, Kasztalska J, Nowak-Kapusta Z, Maciejewska-Paszek I, Grochowska-Niedworok E.
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [Abstract] [Full Text] [Related]

  • 8. The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.
    Farias ML, Delgado AG, Rosenthal D, Vieira JG, Kasamatsu T, Lazarevitch MJ, Pereira MF, Lima MB.
    J Endocrinol Invest; 1996 Jan; 19(1):12-20. PubMed ID: 8851686
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E, Schmidt-Gayk H, Möhring K.
    Eur Urol; 1975 Jan; 1(3):131-3. PubMed ID: 183957
    [Abstract] [Full Text] [Related]

  • 10. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.
    Pak CY, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P.
    Am J Med; 1980 Jul; 69(1):19-30. PubMed ID: 6247914
    [Abstract] [Full Text] [Related]

  • 11. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T, Hirano Y, Ueda D, Niijima T.
    Eur Urol; 1987 Jul; 13(1-2):90-9. PubMed ID: 3034619
    [Abstract] [Full Text] [Related]

  • 12. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis.
    Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL.
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F66-75. PubMed ID: 17210796
    [Abstract] [Full Text] [Related]

  • 13. Renal stone disease, elevated iPTH level and normocalcemia.
    Dimkovic NB, Wallele AA, Oreopoulos DG.
    Int Urol Nephrol; 2002 Jan; 34(1):135-41. PubMed ID: 12549656
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B, Lippuner K, Takkinen R, Villiger L, Ackermann D, Jaeger P.
    Nephrol Dial Transplant; 1995 Jan; 10(9):1614-9. PubMed ID: 8559479
    [Abstract] [Full Text] [Related]

  • 15. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D, Ravery V, Boccon-Gibod L, Friedlander G.
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [Abstract] [Full Text] [Related]

  • 16. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.
    Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A.
    Urol Res; 2011 Feb; 39(1):1-7. PubMed ID: 20490785
    [Abstract] [Full Text] [Related]

  • 17. Physiological basis for absorptive and renal hypercalciurias.
    Pak CY.
    Am J Physiol; 1979 Dec; 237(6):F415-23. PubMed ID: 229736
    [Abstract] [Full Text] [Related]

  • 18. The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure--actions of a permissive hormone.
    Cochran M, Coates PT, Morris HA.
    Clin Nephrol; 2005 Aug; 64(2):98-102. PubMed ID: 16114785
    [Abstract] [Full Text] [Related]

  • 19. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
    Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
    [Abstract] [Full Text] [Related]

  • 20. Renal acidification defects in patients with recurrent calcium nephrolithiasis.
    Tessitore N, Ortalda V, Fabris A, D'Angelo A, Rugiu C, Oldrizzi L, Lupo A, Valvo E, Gammaro L, Loschiavo C.
    Nephron; 1985 Aug; 41(4):325-32. PubMed ID: 4069301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.